Dr Reddy's Laboratories to acquire Dutch specialty pharmaceutical firm OctoPlus for €27.4 mn

22 Oct 2012

1

Dr Reddy's Laboratories today said it will buy Dutch specialty pharmaceutical company OctoPlus NV, for about €27.4 million (Rs193 crore) in cash.

Hyderabad-based Dr. Reddy's is offering €0.52 per share, a premium of 30 per cent on Friday's closing price of OctoPlus on the Euronext Amsterdam Stock Exchange.

OctoPlus said that its board fully supports and recommend the transaction and institutional investors and certain individual members of the board of OctoPlus, holding just over 50 per cent, have agreed to tender their shares to the offer.

Members of the board of OctoPlus have agreed to run OctoPlus during the transition period extending to six months post closing.

OctoPlus also said that it and Dr Reddy's have agreed to enter into a business collaboration agreement for investigational formulation research.

Dr. Reddy's has the right to match any competing offer and OctoPlus has undertaken not to solicit third party offers.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers